Can new biomaterials regrow bone in advanced gum disease?

NCT ID NCT07738705

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests different combinations of biomaterials used during gum surgery to treat class II furcation defects—areas where bone loss has occurred between the roots of molars. The goal is to see which combination best encourages bone regrowth and improves gum thickness. Adults with advanced periodontitis and at least one affected molar may participate. The study measures bone gain and gum changes using 3D imaging over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Surgical procedure using different biomaterial combinations (NovaBone, allograft, microderm or collagen membranes)
What this could lead to
If successful, this could identify a better biomaterial combination to regenerate bone and gum tissue in people with advanced gum disease, potentially improving tooth retention.
What could go wrong
This is a small, early-stage trial with 48 participants, so results may not apply broadly. Surgery carries risks like infection or poor healing, and the outcome depends on individual response.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIODONTAL FURCATION LESIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • LECOM School of Dental Medicine

    Bradenton, Florida, 34211, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.